https://www.avient.com/news/archives?page=76
INVESTOR NEWS
INVESTOR CENTER
Media Relations Contacts
https://www.avient.com/news/archives?page=61
INVESTOR NEWS
INVESTOR CENTER
Media Relations Contacts
https://www.avient.com/news/archives?page=67
INVESTOR NEWS
INVESTOR CENTER
Media Relations Contacts
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
The webcast can be viewed at avient.com/investors, or by clicking here: https://edge.media-
server.com/mmc/p/ko4y5g9z.
A recording of the webcast and the investor presentation will be available at avient.com/
investors.
For the same reasons, the Company is unable to address the probable
significance of the unavailable information.
4
Investor Relations Contact:
Giuseppe (Joe) Di Salvo
Vice President, Treasurer and Investor Relations
Avient Corporation
+1 440-930-1921
giuseppe.disalvo@avient.com
Media Contact:
Kyle G.
https://www.avient.com/sites/default/files/2024-01/Global Standard Response_Dec 2023.pdf
Control of documents and records
All Mevopur related documents and records are
required to be maintained in a legible, readily
identifiable and retrievable manner as evidence that
these products meet specified requirements.
These
standards are designed to mitigate potential health
risks related to food products and or nutraceutical
products from their packaging and/or any other
material that may come into direct contact with it.
Control of documents and records
All ISO 22000 related documents and records are
required to be maintained in a legible, readily
identifiable and retrievable manner as evidence that
these products meet specified requirements.
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
PolyOne Corporation Investor Day 2012
PolyOne Investor Presentation
Sidoti & Company
Eighteenth Annual Emerging Growth
Institutional Investor Forum
March 18, 2014
• In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995.
You are advised to
consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
PolyOne Investor Presentation��Sidoti & Company �Eighteenth Annual Emerging Growth �Institutional Investor Forum�March 18, 2014�
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge To $2.50 Adjusted EPS By 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions that Help Customers Win
Debt Maturities & Pension Funding – 12/31/13
Free Cash Flow and Strong Balance Sheet Fund Investment
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520GS%2520w%2520non%2520GAAP%25205_21_14.pdf
PolyOne Corporation Investor Day 2012
PolyOne Investor Presentation
Goldman Sachs
Basic Materials Conference
May 21, 2014
• In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995.
You are advised to
consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
PolyOne Investor Presentation�Goldman Sachs �Basic Materials Conference �May 21, 2014 �
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
Proof of Performance & 2015 Goals
Bridge to $2.50 Adjusted EPS by 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions
Debt Maturities & Pension Funding – 3/31/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Seaport%2520Global%2520Transports%2520%2526%2520Industrials%2520Confer....pdf
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to
the Securities and Exchange Commission.
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from
personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or
disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; the effect of changes in accounting principles or other
such laws or provisions affecting reported results and tax adjustments.
Segment highlights
COLOR, ADDITIVES & INKS
Color, Additives & Inks
Specialty Engineered Materials
Specialty Engineered Materials
Performance Products & Solutions
Performance Products & Solutions
DISTRIBUTION
Target end markets & �application examples
Slide Number 26
Slide Number 27
Slide Number 28
Slide Number 29
Slide Number 30
Slide Number 31
Slide Number 32
Slide Number 33
Slide Number 34
Slide Number 35
Slide Number 36
Slide Number 37
Investor Presentation - March 2018 r4.pdf
Investor Presentation - March 2018
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Wells%2520Fargo%252005%252008%25202014%2520w%2520non%2520GAAP.pdf
PolyOne Corporation Investor Day 2012
PolyOne Investor Presentation
5th Annual Wells Fargo
Industrial and Construction Conference
May 8, 2014
• In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995.
You are advised to
consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
���PolyOne Investor Presentation�5th Annual Wells Fargo�Industrial and Construction Conference �May 8, 2014 ��
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge to $2.50 Adjusted EPS by 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions
Debt Maturities & Pension Funding – 3/31/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-03/QF-02 QMS Global Standard Response.PDF
Control of documents and records
All Mevopur related documents and records are
required to be maintained in a legible, readily
identifiable and retrievable manner as evidence that
these products meet specified requirements.
These
standards are designed to mitigate potential health
risks related to food products and or nutraceutical
products from their packaging and/or any other
material that may come into direct contact with it.
Control of documents and records
All ISO 22000 related documents and records are
required to be maintained in a legible, readily
identifiable and retrievable manner as evidence that
these products meet specified requirements.